Mridul Agrawal, MD, and Benjamin Hanfstein, MD | iuvando Health
Competition Sponsor: EIT Health
Awardee Year: 2020
iuvando is a patient-centric digital health solution and empowers cancer patients to unlock new care pathways within clinical trials in precision oncology. Many patients are diagnosed with cancer when cure is no longer possible. These patients are depending on therapies to live longer and better with the disease. If established therapies fail, cancer patients rely on new medicines exclusively available within clinical trials.
To learn more about this proposal, email healthylongevity@nas.edu.